Zajecka J M, Fawcett J
Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
Psychiatr Med. 1991;9(1):77-103.
This chapter will briefly review the current theories on the biochemical etiology of depression that are contributing toward the development of innovative somatic treatments. A description of clinically approved pharmacological treatments will be described in detail. Investigational pharmacological treatments that have demonstrated a high probability for general clinical use will also be discussed. Finally, a description of sleep deprivation will be included.